Literature DB >> 10543449

Fluorometric microassays for the determination of cathepsin L and cathepsin S activities in tissue extracts.

B Werle1, A Staib, B Jülke, W Ebert, P Zladoidsky, A Sekirnik, J Kos, E Spiess.   

Abstract

We established a continuous semi-microassay, and for large-scale studies both a stopped and a continuous microtiter plate assay for the fluorometric determination of cathepsin L and cathepsin S activities in body fluids, tissues or cell extracts in the presence of cathepsin B. For the detection of enzymatic activities we used the synthetic substrate Z-Phe-Arg-AMC, and for discrimination between cathepsin L, S and cathepsin B the specific inhibitor CA-074 for blocking interfering cathepsin B activities was applied. Furthermore, we took advantage of the stability of cathepsin S at pH 7.5 for further differentiation between cathepsin L and cathepsin S activities. The kinetic assays were characterized in terms of imprecision, analytical sensitivity, accuracy and substrate concentration. The within-run coefficients of variation were found to be 4.9%-7.2% for the continuous semi-microassay, 10.3%-11.7% for the stopped, and 4.5%-11.8% for the continuous microtiter plate assay. The between-days coefficients of variation for the continuous semi-microassay were 8.1%-8.9%, while for the stopped and continuous microtiter plate assays the coefficients were 11.2%-13.5% and 5.8%-12.2%, respectively. Compared to the continuous semi-microassay, the stopped and the continuous microtiter plate assays showed 3-fold and 11-fold higher sensitivity, respectively. Comparison between the continuous enzyme activity assays at substrate concentrations of 40 microM and 200 microM demonstrated a significant correlation of r = 0.97 and r = 0.99, respectively. The newly developed microtiter plate assay will allow efficient, sensitive and high precision determination of cathepsin L and cathepsin S activities in large-scale studies of cysteine-cathepsin dependent diseases.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10543449     DOI: 10.1515/BC.1999.138

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  10 in total

1.  Novel Small Molecule Entry Inhibitors of Ebola Virus.

Authors:  Arnab Basu; Debra M Mills; Daniel Mitchell; Esther Ndungo; John D Williams; Andrew S Herbert; John M Dye; Donald T Moir; Kartik Chandran; Jean L Patterson; Lijun Rong; Terry L Bowlin
Journal:  J Infect Dis       Date:  2015-07-22       Impact factor: 5.226

2.  TsAg5, a Taenia solium cysticercus protein with a marginal trypsin-like activity in the diagnosis of human neurocysticercosis.

Authors:  Analiz Rueda; Cecilia Sifuentes; Robert H Gilman; Andrés H Gutiérrez; Ruby Piña; Nancy Chile; Sebastián Carrasco; Sandra Larson; Holger Mayta; Manuela Verástegui; Silvia Rodriguez; Marcel Gutiérrez-Correa; Héctor H García; Patricia Sheen; Mirko Zimic
Journal:  Mol Biochem Parasitol       Date:  2011-08-26       Impact factor: 1.759

3.  Upregulation of elastase proteins results in aortic dilatation in mucopolysaccharidosis I mice.

Authors:  Xiucui Ma; Mindy Tittiger; Russell H Knutsen; Attila Kovacs; Laura Schaller; Robert P Mecham; Katherine P Ponder
Journal:  Mol Genet Metab       Date:  2008-05-13       Impact factor: 4.797

4.  Utility of a protein fraction with cathepsin L-Like activity purified from cysticercus fluid of Taenia solium in the diagnosis of human cysticercosis.

Authors:  Mirko Zimic; Mónica Pajuelo; Daniel Rueda; César López; Yanina Arana; Yesenia Castillo; Maritza Calderón; Silvia Rodriguez; Patricia Sheen; Joseph M Vinetz; Armando Gonzales; Héctor H García; Robert H Gilman
Journal:  Am J Trop Med Hyg       Date:  2009-06       Impact factor: 2.345

5.  Upregulation of elastase activity in aorta in mucopolysaccharidosis I and VII dogs may be due to increased cytokine expression.

Authors:  Jason A Metcalf; Bruce Linders; Susan Wu; Paul Bigg; Patricia O'Donnell; Meg M Sleeper; Michael P Whyte; Mark Haskins; Katherine P Ponder
Journal:  Mol Genet Metab       Date:  2009-12-11       Impact factor: 4.797

6.  Cancer-associated mutations reveal a novel role for EpCAM as an inhibitor of cathepsin-L and tumor cell invasion.

Authors:  Narendra V Sankpal; Taylor C Brown; Timothy P Fleming; John M Herndon; Anusha A Amaravati; Allison N Loynd; William E Gillanders
Journal:  BMC Cancer       Date:  2021-05-12       Impact factor: 4.430

7.  Cathepsin S in tumours, regional lymph nodes and sera of patients with lung cancer: relation to prognosis.

Authors:  J Kos; A Sekirnik; G Kopitar; N Cimerman; K Kayser; A Stremmer; W Fiehn; B Werle
Journal:  Br J Cancer       Date:  2001-10-19       Impact factor: 7.640

8.  Cysteine proteinase cathepsin H in tumours and sera of lung cancer patients: relation to prognosis and cigarette smoking.

Authors:  A Schweiger; A Staib; B Werle; M Krasovec; T T Lah; W Ebert; V Turk; J Kos
Journal:  Br J Cancer       Date:  2000-02       Impact factor: 7.640

9.  Protein Never in Mitosis Gene A Interacting-1 regulates calpain activity and the degradation of cyclooxygenase-2 in endothelial cells.

Authors:  Tongzheng Liu; Ryan A Schneider; Vaibhav Shah; Yongcheng Huang; Rostislav I Likhotvorik; Lakhu Keshvara; Dale G Hoyt
Journal:  J Inflamm (Lond)       Date:  2009-06-22       Impact factor: 4.981

10.  Role of Endogenous Cathepsin L in Muscle Protein Degradation in Olive Flounder (Paralichthys olivaceus) Surimi Gel.

Authors:  Chang Woo Kwon; Pahn-Shick Chang
Journal:  Molecules       Date:  2021-03-28       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.